Moderate Aortic Valve Stenosis Clinical Trials
3 recruiting trials for Moderate Aortic Valve Stenosis. Eligibility criteria explained in plain English.
TrialFinderData lists 3 Moderate Aortic Valve Stenosis clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Every phased trial in this set is Phase 2 / Phase 3 (1 of the listed studies); the remaining records are observational or have no phase recorded on ClinicalTrials.gov.
Research is led by Second Affiliated Hospital, School of Medicine, Zhejiang University (1), Kardigan, Inc. (1), St. Antonius Hospital (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Ataciguat (drug, 1 trial), followed by Placebo, Quality of life questionnaires will be assessed in addition to standard care.
Track Moderate Aortic Valve Stenosis trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Prospective Observational Cohort Study of Moderate Aortic Valve Disease
The objective of this research is to evaluate and predict the progression of moderate aortic stenosis and regurgitation from clinical characterization, biological,...
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
The purpose of this study is to evaluate if ataciguat slows the progression of moderate calcific aortic valve stenosis in adults.
Future Optimal Research and Care Evaluation - Aortic Stenosis
In the past decade the treatment of aortic valve stenosis has rapidly changed. At first, transcatheter aortic valve implantation (TAVI) was a last resort option for inoperable...
Explore Other Conditions
Frequently Asked Questions
There are currently 3 clinical trials for Moderate Aortic Valve Stenosis, with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Moderate Aortic Valve Stenosis, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Moderate Aortic Valve Stenosis, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.